trending Market Intelligence /marketintelligence/en/news-insights/trending/DJ8YEIiV_WXWz8JPz3wMGQ2 content esgSubNav
In This List

Cytori Therapeutics director to step down

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Cytori Therapeutics director to step down

Cytori Therapeutics Inc. director Paul Hawran will not stand for re-election at the company's annual meeting.

He will be replaced by Gregg Lapointe, who was recently appointed to the company board.